Autres langues Inogen, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
7,15 ^USD	+1,71%		+5,46%	+30,24%

28/02	Les plus fortes baisses du midi	MT
28/02	Les plus fortes baisses du premarket	MT

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024	10/04
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference	25/03
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	07/03
Top Midday Decliners	28/02
Top Premarket Decliners	28/02
Inogen: Q4 Earnings Snapshot	27/02
Earnings Flash (INGN) INOGEN Posts Q4 Revenue $75.9M, vs. Street Est of $77M	27/02
Inogen, Inc. Provides Earnings Guidance for the First Quarter 2024	27/02
Inogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Inogen, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results	27/02
North American Morning Briefing : S&P 500 Seen -2-	16/02
Sector Update: Health Care Stocks Higher Late Afternoon	15/02
Sector Update: Health Care	15/02
Inogen Shares Rise After Upgrade From William Blair	15/02
Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024	30/01
Inogen Names Michael Bourque as Finance Chief	25/01
Inogen, Inc. Announces CFO Changes, Effective March 4, 2024	24/01
Inogen, Inc. Announces Executive Changes, Effective March 4, 2024	24/01
Inogen Names Michael Bourque as New Chief Financial Officer	24/01

Aucun résultat pour cette recherche